DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Sano T, Akuta N, Suzuki F. , et al.
Role of NS5A-L31/Y93 double wild-type in failure of glecaprevir/pibrentasvir double therapy in two patients with a history of direct-acting antiviral agent failure: an ultra-deep sequencing analysis.
Intern Med 2019;
58 (18) 2657-2662
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.